This research was funded by Additional Ventures - Single Ventricle Research Fund (SVRF) and Single Ventricle Expansion Fund (to I.F.) and a Marietta Blau scholarship of the OeAD-GmbH from funds provided by the Austrian Federal Ministry of Education, Science and Research BMBWFC (to G.G.).

All the animal procedures were conducted in accordance with the National Research Council. 2011. Guide for the Care and Use of Laboratory Animals: Eighth Edition. The animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee at Boston Children&#39;s Hospital.
Prior to surgery, all the surgical instruments are steam-autoclaved, and modified Krebs-Henseleit buffer, with a final concentration of 22 mmol/L KCl, is prepared as a cardioplegic solution (Table 1). The solution is filter-sterilized and stored at 4 &#176;C overnight. A surgical microscope (12.5x) is required for the heterotopic neonatal rat heart transplantation procedure.
1. Preparation and anesthesia
<ol>
	<li>Use male/female Lewis rats with a weight of around 150 g (5-6 weeks of age) as recipients.</li>
	<li>To start, generously shave the rat&#39;s abdomen with a razor.</li>
	<li>Place the rat into an isoflurane chamber, and turn on the oxygen flow at 2 L/min with 2% isoflurane until the animal is properly sedated but still spontaneously breathing. Inject 45 mg/kg ketamine and 5 mg/kg xylazine intraperitoneally (IP), as well as 300 U/kg heparin. Confirm proper anesthetization with a toe pinch test. 
	NOTE: Carefully monitor the spontaneous breathing and heart rate through palpation of the chest to assure a stable hemodynamic status throughout the entire process.</li>
	<li>For intubation, place the rat on an oblique shelf (Figure 1), secure the front teeth with a string, and place the head facing toward the surgeon.</li>
	<li>Place the light on the outside of the neck onto the area of the vocal cords, grab the tongue with two fingers, and slightly push it upward and to the left to provide optimal vision for intubation. Use an 18 G, 2 in cannula for a 100-150 g rat. Secure the intratracheal tube with tape. 
	NOTE: Surgical loups with 3.5x magnification are recommended for intubation.</li>
	<li>Connect the intubation cannula to the small animal ventilator, and adjust the settings according to the manufacturer&#39;s instructions based on the animal size. 
	NOTE: Use the following settings for a 150 g rat: volume mode; respiratory rate, 55/min; tidal volume, 1.3 mL 50 % I/E ratio, but this can be adjusted appropriately as needed. Assure proper bilateral and equal chest movement, and administer isoflurane continuously at 0.5%&#8211;2% through the ventilator.</li>
	<li>Place the rat on a heating pad (to maintain normal body temperature) in a supine position with the tail facing toward the surgeon. Sterilize the abdomen three times with betadine solution and 70% of ethanol alternatingly. Administer eye lube, and cover the rat with a sterile surgical drape, leaving the abdomen uncovered.</li>
</ol>
2. Surgical preparation and heterotopic transplantation of the neonatal donor heart in the recipient rat
<ol>
	<li>Perform a midline laparotomy using a 15 blade scalpel for the skin incision, and use scissors to open the anterior abdominal wall, followed by blunt exposure of the retroperitoneal abdominal aorta and inferior vena cava (IVC) with cotton tip applicators.</li>
	<li>Mobilize the intestines (including the descending colon), and place them toward the right upper quadrant. Cover the intestines with warm saline-soaked gauze. Use retractors to ensure optimal exposure of the IVC and abdominal aorta.</li>
	<li>Perform blunt dissection of the infrarenal IVC and abdominal aorta up toward the bifurcation. Ligate all the infrarenal branching arteries and veins (e.g., inferior mesenteric artery and lymph node arteries) with a 10-0 nylon suture. 
	NOTE: There is great variability in the anatomy of these side branches. Monitor the aorta&#39;s pulse and heart rate visually when no other hemodynamic monitoring is available. Assess the proper depth of anesthesia every 15 min through a toe pinch test. Adjust the isoflurane concentration accordingly.</li>
	<li>After the donor heart is harvested from a neonatal rat, deliver the excised heart in sterile conditions in a surgical basin containing Krebs-Henseleit buffer to the surgical field. Irrigate the donor heart intermittently with ice-cold cardioplegic solution. 
	NOTE: When a second surgeon is available, the heart should be prepared at the same time, as a second surgeon reduces the total anesthesia time of the recipient animal and the ischemia time of the donor heart. When a second surgeon is not available, cover the recipient&#39;s abdomen with warm saline, and monitor the animal during the harvesting procedure.</li>
	<li>Apply four small atraumatic vascular clamps to the distal and proximal segments of the infrarenal aorta and IVC. If needed, temporarily occlude an unfavorable renal vessel with a 7-0 silk suture, and release the suture after the procedure. Place a 10-0 nylon suture vertically onto the anterior wall of the aorta to facilitate the aortotomy. Perform an aortotomy with two small horizontal cuts (wedge-shaped) with microscissors by slightly pulling up the suture. 
	NOTE: To remove any blood clots, flushing of the aortic lumen with heparinized saline is recommended.</li>
	<li>Place the donor heart on the left side (from the animal&#8217;s perspective) of the aorta and secure the recipient&#8217;s infrarenal aorta and the donor&#8217;s ascending aorta end-to-side at the 12 o&#8217;clock and 6 o&#8217;clock positions of the aortotomy with sutures. Continue with the third and fourth sutures at the 3 o&#8217;clock and 9 o&#8217;clock positions, gently flipping the heart over to the right side of the aorta after the third suture. Complete the arterial anastomosis by adding one to two sutures to every interspace. 
	NOTE: Care should be taken to avoid touching either the donor&#39;s ascending aorta or the recipient&#39;s abdominal aorta with forceps when creating the anastomosis to avoid tissue damage.</li>
	<li>Rotate the rat counterclockwise, with the head facing toward the surgeon&#39;s left hand. Move the donor&#39;s aorta to the left side of the abdominal aorta to allow optimal sight onto the IVC.</li>
	<li>Perform a venotomy on the IVC, slightly proximal to the aortic anastomosis, using an 11 blade for puncture and microscissors for adequate size adjustment according to the diameter of the donor&#39;s pulmonary trunk. Again, flush the intracaval lumen with heparinized saline.</li>
	<li>Start with the venous anastomosis between the recipient&#39;s IVC and donor&#39;s pulmonary trunk, which is best achieved by placing interrupted 11-0 nylon sutures on the back wall of the vessel, starting at the 12 o&#39;clock and 6 o&#39;clock positions (related to the IVC), and then place a continuous 11-0 nylon suture on the front wall (from the 6 o&#39;clock toward the 12 o&#39;clock position).</li>
	<li>Cover the anastomoses with small strips of an absorbable gelatin sponge, and remove the microvascular clamps starting distally. Use a cotton tip applicator to lightly compress the sponges to obtain optimal hemostasis.</li>
	<li>Observe the graft&#39;s coronary vessels filling at the time of the release of the distal microvascular clamps, and make sure that the donor heart starts beating immediately when the proximal clamp is released. 
	NOTE: The graft&#39;s viability can be scored from 0 to 4 intraoperatively according to a modified Stanford score19 to confirm adequate graft function.</li>
	<li>Place the intestines back into the abdomen by ensuring not to distort the arterial and venous anastomosis.</li>
	<li>Administer meloxicam (1mg/kg) and ethiqa XR (0.65 mg/kg) subcutaneously while the animal is fully anesthezised to ascertain postoperative analgesia. Then, close the abdominal wall with a continuous 5-0 absorbable vicryl suture before closing the skin with a 6-0 absorbable vicryl suture intracutaneously. 
	&#8203;NOTE: Guidance regarding common failures and troubleshooting is presented in Table 2.</li>
</ol>
3. Harvesting of the neonatal donor heart
<ol>
	<li>Place the neonatal donor rat in a chamber insufflated with isoflurane (2%) for sedation. Administer ketamine (75 mg/kg) and xylazine (5 mg/kg), as well as heparin (300 U/kg) intraperitoneally.</li>
	<li>Confirm the depth of anesthesia by toe pinch, and place the rat in a supine position with the tail facing toward you. Sterilize the entire thorax and abdominal wall with betadine and 70% ethanol three times alternatively. Cover the rat with a sterile surgical drape.</li>
	<li>Using a 12.5x surgical microscope, remove the entire anterior thoracic wall by starting with a horizontal incision using a 15 blade scalpel at the xyphoid followed by vertical incisions laterally up to the axillae on both sides with scissors. The anterior thoracic wall can then be removed by continuing with another horizontal incision right beneath the neck.</li>
	<li>Dissect the IVC, right and left superior vena cavae, and pulmonary vessels with scissors, and then encircle and ligate all the vessels with a 7-0 silk suture. Administer 3 mL of ice-cold, high-potassium modified Krebs-Henseleit solution to the right atrium by puncturing the IVC with a 30 G needle and slightly pushing the diaphragm down with forceps.</li>
	<li>Cut the IVC, SVCs, pulmonary vessels, and aorta with scissors. Transect the pulmonary arteries as far as possible and the aorta distal to the brachiocephalic trunk to ensure proper length using a 11 blade scalpel.</li>
	<li>Separate the pulmonary trunk and ascending aorta with microscissors, and flush the heart with ice cold cardioplegic solution using a 3 mL syringe.</li>
</ol>
4. Recovery of the recipient and graft monitoring
<ol>
	<li>After surgery, give the rat ample time to wake up, which usually occurs in a 15 min time window, and let it recover on a heating pad. 
	NOTE: No antibiotics are necessary due to the very low risk of infection and in order to not compromise the experimental model, and no restriction to food or water is applied.</li>
	<li>Following transplantation, monitor the graft function by palpation of the transplanted heart daily, but consider that this can sometimes be difficult to assess due to intestine overlay. 
	NOTE: Abdominal echocardiography can more accurately measure the graft viability. For echocardiography, sedate the rat slightly with isoflurane (1-2%) inhaled through a nose cone, and position it on a heating pad. Echocardiography is usually performed on postoperative day (POD) 1, POD 7, and POD 14. To allow for the assessment of the heart rate and contractility, one can easily obtain long-axis and short-axis views (Figure 2A, B). To evaluate the anastomoses, use Doppler echocardiography (Figure 3A), and confirm the formation of EFE tissue as seen as an echo-bright endocardial layer within the left ventricular cavity (Figure 3B, C).</li>
</ol>

In Vivo Heart Transplantation to Study Endothelial-to-Mesenchymal Transition

<ol><li>Lurie, P. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Changing+concepts+of+endocardial+fibroelastosis%5BTitle%5D)+AND+%22Cardiology+in+the+Young%22%5BJournal%5D)">Changing concepts of endocardial fibroelastosis.</a> Cardiology in the Young. 20 (2), 115-123 (2010).</li>
<li>Crucean, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Re-evaluation+of+hypoplastic+left+heart+syndrome+from+a+developmental+and+morphological+perspective%5BTitle%5D)+AND+%22Orphanet+Journal+of+Rare+Diseases%22%5BJournal%5D)">Re-evaluation of hypoplastic left heart syndrome from a developmental and morphological perspective.</a> Orphanet Journal of Rare Diseases. 12 (1), 138(2017).</li>
<li>Xu, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Endocardial+fibroelastosis+is+caused+by+aberrant+endothelial+to+mesenchymal+transition%5BTitle%5D)+AND+%22Circulation+Research%22%5BJournal%5D)">Endocardial fibroelastosis is caused by aberrant endothelial to mesenchymal transition.</a> Circulation Research. 116 (5), 857-866 (2015).</li>
<li>Eisenberg, L. M., Markwald, R. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Molecular+regulation+of+atrioventricular+valvuloseptal+morphogenesis%5BTitle%5D)+AND+%22Circulation+Research%22%5BJournal%5D)">Molecular regulation of atrioventricular valvuloseptal morphogenesis.</a> Circulation Research. 77 (1), 1-6 (1995).</li>
<li>Illigens, B. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Vascular+endothelial+growth+factor+prevents+endothelial-to-mesenchymal+transition+in+hypertrophy%5BTitle%5D)+AND+%22Annals+of+Thoracic+Surgery%22%5BJournal%5D)">Vascular endothelial growth factor prevents endothelial-to-mesenchymal transition in hypertrophy.</a> Annals of Thoracic Surgery. 104 (3), 932-939 (2017).</li>
<li>Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M., Kalluri, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fibroblasts+in+kidney+fibrosis+emerge+via+endothelial-to-mesenchymal+transition%5BTitle%5D)+AND+%22Journal+of+the+American+Society+of+Nephrology%22%5BJournal%5D)">Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.</a> Journal of the American Society of Nephrology. 19 (12), 2282-2287 (2008).</li>
<li>Zeisberg, E. M., Potenta, S., Xie, L., Zeisberg, M., Kalluri, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Discovery+of+endothelial+to+mesenchymal+transition+as+a+source+for+carcinoma-associated+fibroblasts%5BTitle%5D)+AND+%22Cancer+Research%22%5BJournal%5D)">Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.</a> Cancer Research. 67 (21), 10123-10128 (2007).</li>
<li>Souilhol, C., Harmsen, M. C., Evans, P. C., Krenning, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Endothelial-mesenchymal+transition+in+atherosclerosis%5BTitle%5D)+AND+%22Cardiovascular+Research%22%5BJournal%5D)">Endothelial-mesenchymal transition in atherosclerosis.</a> Cardiovascular Research. 114 (4), 565-577 (2018).</li>
<li>Zeisberg, E. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Endothelial-to-mesenchymal+transition+contributes+to+cardiac+fibrosis%5BTitle%5D)+AND+%22Nature+Medicine%22%5BJournal%5D)">Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.</a> Nature Medicine. 13 (8), 952-961 (2007).</li>
<li>Rieder, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Inflammation-induced+endothelial-to-mesenchymal+transition%3A+A+novel+mechanism+of+intestinal+fibrosis%5BTitle%5D)+AND+%22American+Journal+of+Pathology%22%5BJournal%5D)">Inflammation-induced endothelial-to-mesenchymal transition: A novel mechanism of intestinal fibrosis.</a> American Journal of Pathology. 179 (5), 2660-2673 (2011).</li>
<li>Johnson, F. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Anoxia+as+a+cause+of+endocardial+fibroelastosis+in+infancy%5BTitle%5D)+AND+%22AMA+Archives+of+Pathology%22%5BJournal%5D)">Anoxia as a cause of endocardial fibroelastosis in infancy.</a> AMA Archives of Pathology. 54 (3), 237-247 (1952).</li>
<li>Shimada, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Distention+of+the+immature+left+ventricle+triggers+development+of+endocardial+fibroelastosis%3A+An+animal+model+of+endocardial+fibroelastosis+introducing+morphopathological+features+of+evolving+fetal+hypoplastic+left+heart+syndrome%5BTitle%5D)+AND+%22Biomedical+Research%22%5BJournal%5D)">Distention of the immature left ventricle triggers development of endocardial fibroelastosis: An animal model of endocardial fibroelastosis introducing morphopathological features of evolving fetal hypoplastic left heart syndrome.</a> Biomedical Research. 2015, 462-469 (2015).</li>
<li>Weixler, V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Flow+disturbances+and+the+development+of+endocardial+fibroelastosis%5BTitle%5D)+AND+%22Journal+of+Thoracic+and+Cardiovascular+Surgery%22%5BJournal%5D)">Flow disturbances and the development of endocardial fibroelastosis.</a> Journal of Thoracic and Cardiovascular Surgery. 159 (2), 637-646 (2020).</li>
<li>Purevjav, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Nebulette+mutations+are+associated+with+dilated+cardiomyopathy+and+endocardial+fibroelastosis%5BTitle%5D)+AND+%22Journal+of+the+American+College+of+Cardiology%22%5BJournal%5D)">Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis.</a> Journal of the American College of Cardiology. 56 (18), 1493-1502 (2010).</li>
<li>Friehs, I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+animal+model+of+endocardial+fibroelastosis%5BTitle%5D)+AND+%22Journal+of+Surgical+Research%22%5BJournal%5D)">An animal model of endocardial fibroelastosis.</a> Journal of Surgical Research. 182 (1), 94-100 (2013).</li>
<li>Emani, S. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Staged+left+ventricular+recruitment+after+single-ventricle+palliation+in+patients+with+borderline+left+heart+hypoplasia%5BTitle%5D)+AND+%22Journal+of+the+American+College+of+Cardiology%22%5BJournal%5D)">Staged left ventricular recruitment after single-ventricle palliation in patients with borderline left heart hypoplasia.</a> Journal of the American College of Cardiology. 60 (19), 1966-1974 (2012).</li>
<li>Hickey, E. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Critical+left+ventricular+outflow+tract+obstruction%3A+The+disproportionate+impact+of+biventricular+repair+in+borderline+cases%5BTitle%5D)+AND+%22Journal+of+Thoracic+and+Cardiovascular+Surgery%22%5BJournal%5D)">Critical left ventricular outflow tract obstruction: The disproportionate impact of biventricular repair in borderline cases.</a> Journal of Thoracic and Cardiovascular Surgery. 134 (6), 1429-1436 (2007).</li>
<li>Oh, N. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Abnormal+flow+conditions+promote+endocardial+fibroelastosis+via+endothelial-to-mesenchymal+transition%2C+which+is+responsive+to+losartan+treatment%5BTitle%5D)+AND+%22JACC%3A+Basic+to+Translational+Science%22%5BJournal%5D)">Abnormal flow conditions promote endocardial fibroelastosis via endothelial-to-mesenchymal transition, which is responsive to losartan treatment.</a> JACC: Basic to Translational Science. 6 (12), 984-999 (2021).</li>
<li>Blanchard, J. M., Pollak, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Techniques+for+perfusion+and+storage+of+heterotopic+heart+transplants+in+mice%5BTitle%5D)+AND+%22Microsurgery%22%5BJournal%5D)">Techniques for perfusion and storage of heterotopic heart transplants in mice.</a> Microsurgery. 6 (3), 169-174 (1985).</li>
<li>Kokudo, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Snail+is+required+for+TGFbeta-induced+endothelial-mesenchymal+transition+of+embryonic+stem+cell-derived+endothelial+cells%5BTitle%5D)+AND+%22Journal+of+Cell+Science%22%5BJournal%5D)">Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells.</a> Journal of Cell Science. 121 (20), 3317-3324 (2008).</li>
<li>Wu, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Endocardial+cells+form+the+coronary+arteries+by+angiogenesis+through+myocardial-endocardial+VEGF+signaling%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling.</a> Cell. 151 (5), 1083-1096 (2012).</li>
<li>Clark, E. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+mouse+model+of+endocardial+fibroelastosis%5BTitle%5D)+AND+%22Cardiovascular+Pathology%22%5BJournal%5D)">A mouse model of endocardial fibroelastosis.</a> Cardiovascular Pathology. 24 (6), 388-394 (2015).</li>
<li>Kovacic, J. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Endothelial+to+mesenchymal+transition+in+cardiovascular+disease%3A+JACC+state-of-the-art+review%5BTitle%5D)+AND+%22Journal+of+the+American+College+of+Cardiology%22%5BJournal%5D)">Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review.</a> Journal of the American College of Cardiology. 73 (2), 190-209 (2019).</li>
<li>Derynck, R., Zhang, Y. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Smad-dependent+and+Smad-independent+pathways+in+TGF-beta+family+signalling%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Smad-dependent and Smad-independent pathways in TGF-beta family signalling.</a> Nature. 425 (6958), 577-584 (2003).</li>
<li>Daugherty, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Recommendation+on+design%2C+execution%2C+and+reporting+of+animal+atherosclerosis+studies%3A+A+scientific+statement+from+the+American+Heart+Association%5BTitle%5D)+AND+%22Arteriosclerosis%2C+Thrombosis%2C+and+Vascular+Biology%22%5BJournal%5D)">Recommendation on design, execution, and reporting of animal atherosclerosis studies: A scientific statement from the American Heart Association.</a> Arteriosclerosis, Thrombosis, and Vascular Biology. 37 (9), e131-e157 (2017).</li>
</ol>

This animal model of heterotopic transplantation of a neonatal donor rat heart into the recipient&#39;s abdomen creates the possibility to study EndMT-derived fibrosis through detailed histological tissue evaluation, identify regulatory signaling pathways, and test treatment options. Since EndMT is the underlying mechanism for fibrotic diseases of the heart, this model has great value in the field of pediatric cardiac surgery and beyond. In this model, many factors can negatively influence the outcome of the procedure. T...

Endocardial fibroelastosis (EFE), defined by the accumulation of collagen and elastic fibers in the subendocardial tissue, presents as a pearly or opaque thickened endocardium; EFE undergoes most active growth during the fetal period and early infancy1. In an autopsy study, 70% of cases with hypoplastic left heart syndrome (HLHS) were associated with the presence of EFE2.
Cells expressing markers for fibroblasts are the main cell population in EFE, but these cells also concomitantly express endocardial endothelial markers, which is an indication of the origin of these EFE cells. Our group previously established that the underlying mechanism of EFE formation involves a phenotypical change of endocardial endothelial cells to fibroblasts through endothelial-to-mesenchymal transition (EndMT)3. EndMT can be detected using immunohistochemical double-staining for endothelial markers such as cluster of differentiation (CD) 31 or vascular endothelial (VE)-cadherin (CD144) and fibroblast markers (e.g., alpha-smooth muscle actin, &#945;-SMA). Furthermore, we also previously established the regulatory role of the TGF-&#223; pathway in this process with activation of the transcription factors SLUG, SNAIL, and TWIST3.
EndMT is a physiological process that occurs during embryonic cardiac development and leads to the formation of the septa and valves from endocardial cushions4, but it also causes organ fibrosis in heart failure, kidney fibrosis, or cancer and plays a key role in vascular atherosclerosis5,6,7,8. EndMT in cardiac fibrosis is mainly regulated through the TGF-&#946; pathway, as we and others have reported3,9. Various stimuli have been described to induce EndMT: inflammation10, hypoxia11, mechanical alterations12, and flow disturbances, including alterations of the intracavitary blood flow13, and EndMT may also be a consequence of a genetic disease14.
This animal model was developed using the key components of cardiac EFE development, which are immaturity and alterations of the intracavitary blood flow, specifically flow stagnation. Immaturity was fulfilled by using neonatal rat hearts as donors, since neonatal rats are known to be developmentally immature immediately after birth. Heterotopic heart transplantation offered the provision of intracavitary flow restriction15.
From a clinical point of view, this animal model allows for better investigating the impact of EndMT on the growing left ventricle (LV). The growth restriction imposed on the fetal and neonatal heart through EndMT-induced EFE formation16 precludes patients with left ventricular outflow tract obstructions (LVOTO) such as congenital critical aortic stenosis and hypoplastic left heart syndrome (HLHS) from curative anatomical biventricular surgical repair17. This animal model facilitates the study of the cellular mechanisms and regulation of tissue formation through EndMT and allows for the testing of pharmacological treatment options3,18.
Transabdominal echocardiography is used to monitor the graft viability, contractility, and the patency of the anastomoses. Following euthanasia, EFE formation can be macroscopically observed within 3 days after transplantation. EFE tissue shows the same histopathological characteristics as human EFE tissue from patients with LVOTO.
Hence, this animal model, though developed for pediatric use in the spectrum of HLHS, can be applied when studying various diseases based on the molecular mechanism of EndMT.

<table><tbody><tr><td>Advanced Ventilator System For Rodents, SAR-1000</td><td>CWE, Inc.</td><td>12-03100</td><td>small animal ventilator</td></tr><tr><td>aSMA</td><td>Sigma</td><td>A2547</td><td>Antibody for Immunohistochemistry</td></tr><tr><td>Axio observer Z1&amp;nbsp;</td><td>Carl Zeiss</td><td></td><td>inverted microscope</td></tr><tr><td>Betadine&amp;nbsp;Solution</td><td>Avrio Health L.P.</td><td>367618150092</td><td></td></tr><tr><td>CD31</td><td>Invitrogen</td><td>MA1-80069</td><td>Antibody for Immunohistochemistry</td></tr><tr><td>DAPI</td><td>Invitrogen</td><td>D1306</td><td>Antibody for Immunohistochemistry</td></tr><tr><td>DemeLON Nylon black 10-0</td><td>DemeTECH</td><td>NL76100065F0P</td><td>10-0 Nylon suture</td></tr><tr><td>ETFE IV Catheter, 18G x 2</td><td>TERUMO SURFLO</td><td>SR-OX1851CA</td><td>intubation cannula</td></tr><tr><td>Micro Clip 8mm</td><td>Roboz Surgical Instrument Co.</td><td>RS-6471</td><td>microvascular clamps</td></tr><tr><td>Nylon black monofilament 11-0</td><td>SURGICAL SPECIALTIES CORP</td><td>AA0130</td><td>11-0 Nylon</td></tr><tr><td>O.C.T. Compound</td><td>Tissue-Tek</td><td>4583</td><td>Embedding medium for frozen tissue specimen</td></tr><tr><td>p-SMAD2/3</td><td>Invitrogen</td><td>PA5-110155</td><td>Antibody for Immunohistochemistry</td></tr><tr><td>Rodent, Tilting WorkStand</td><td>Hallowell EMC.</td><td>000A3467</td><td>oblique shelf for intubation</td></tr><tr><td>Silk Sutures, Non-absorbable, 7-0</td><td>Braintree Scientific</td><td>NC9201231</td><td>Silk suture</td></tr><tr><td>Slug/Snail</td><td>Abcam</td><td>ab180714</td><td>Antibody for Immunohistochemistry</td></tr><tr><td>Undyed Coated Vicryl 5-0 P-3 18&quot;</td><td>Ethicon</td><td>J493G</td><td>5-0 Vicryl</td></tr><tr><td>Undyed Coated Vicryl 6-0 P-3 18&quot;</td><td>Ethicon</td><td>J492G</td><td>6-0 Vicryl</td></tr><tr><td>VE-Cadherin</td><td>Abcam</td><td>ab231227</td><td>Antibody for Immunohistochemistry</td></tr><tr><td>Zeiss OPMI 6-SFR</td><td>Zeiss</td><td></td><td>Surgical microscope</td></tr><tr><td>Zen, Blue Edition, 3.6</td><td>Zen&amp;nbsp;</td><td></td><td>inverted microscope software</td></tr></tbody></table>

a neonatal heterotopic rat heart transplantation model for the study of endothelial-to-mesenchymal transition

Endocardial fibroelastosis (EFE), defined by subendocardial tissue accumulation, has major impacts on the development of the left ventricle (LV) and precludes patients with congenital critical aortic stenosis and hypoplastic left heart syndrome (HLHS) from curative anatomical biventricular surgical repair. Surgical resection is currently the only available therapeutic option, but EFE often recurs, sometimes with an even more infiltrative growth pattern into the adjacent myocardium.
To better understand the underlying mechanisms of EFE and to explore therapeutic strategies, an animal model suitable for preclinical testing was developed. The animal model takes into consideration that EFE is a disease of the immature heart and is associated with flow disturbances, as supported by clinical observations. Thus, the heterotopic heart transplantation of neonatal rat donor hearts is the basis for this model.
A neonatal rat heart is transplanted into an adolescent rat&#39;s abdomen and connected to the recipient&#39;s infrarenal aorta and inferior vena cava. While perfusion of the coronary arteries preserves the viability of the donor heart, flow stagnation within the LV induces EFE growth in the very immature heart. The underlying mechanism of EFE formation is the transition of endocardial endothelial cells to mesenchymal cells (EndMT), which is a well-described mechanism of early embryonic development of the valves and septa but also the leading cause of fibrosis in heart failure. EFE formation can be macroscopically observed within days after transplantation. Transabdominal echocardiography is used to monitor the graft viability, contractility, and the patency of the anastomoses. Following euthanasia, the EFE tissue is harvested, and it shows the same histopathological characteristics as human EFE tissue from HLHS patients.
This in vivo model allows for studying the mechanisms of EFE development in the heart and testing treatment options to prevent this pathological tissue formation and provides the opportunity for a more generalized examination of EndMT-induced fibrosis.

Graft viability and beating 
In this work, the graft viability was visually assessed after all the clamps had been removed, and an approximate reperfusion time of 10-15 min was allowed with an open abdomen for observation of the graft. The same scoring system to objectively verify graft viability was used for visual assessment at the end of surgery and for the echocardiography on POD 1, POD 7, and POD 14.
0 = no organ function; 1 = (rest) organ function, only minimal cont...

Watch this Scientific Journal Video about A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition at JoVE.com

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition  

This work presents an animal model of endothelial-to-mesenchymal transition-induced fibrosis, as seen in congenital cardiac defects such as critical aortic stenosis or hypoplastic left heart syndrome, which allows for detailed histological tissue evaluation, the identification of regulatory signaling pathways, and the testing of treatment options.

A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Endocardial fibroelastosis (EFE), defined by subendocardial tissue accumulation, has major impacts on the development of the left ventricle (LV) and ...

a-neonatal-heterotopic-rat-heart-transplantation-model-for-study

Research

JoVE Journal

Medicine

1.2K Views.  Harvard Medical School. This work presents an animal model of endothelial-to-mesenchymal transition-induced fibrosis, as seen in congenital cardiac defects such as critical aortic stenosis or hypoplastic left heart syndrome, which allows for detailed histological tissue evaluation, the identification of regulatory signaling pathways, and the testing of treatment options. 

Video: Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition  

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy

Research models of chronic rejection are essential to investigate pathobiological and pathophysiological processes during the development of transplant vasculopathy (TVP).
The commonly used animal model for cardiovascular chronic rejection studies is the heterotopic heart transplant model performed in laboratory rodents. This model is used widely in experiments since Ono and Lindsey (3) published their technique. To analyze the findings in the blood vessels, the heart has to be sectioned and all vessels have to be measured.
Another method to investigate chronic rejection in cardiovascular questionings is the aortic transplant model (1, 2). In the orthotopic aortic transplant model, the aorta can easily be histologically evaluated (2). The PVG-to-ACI model is especially useful for CAV studies, since acute vascular rejection is not a major confounding factor and Cyclosporin A (CsA) treatment does not prevent the development of CAV, similar to what we find in the clinical setting (4). A7-day period of CsA is required in this model to prevent acute rejection and to achieve long-term survival with the development of TVP.
This model can also be used to investigate acute cellular rejection and media necrosis in xenogeneic models (5).

This video demonstrates the orthotopic aortic transplant model as a simple model to study the development of transplant vasculopathy (TVP) in rats.

Research models of chronic rejection are essential to investigate pathobiological and pathophysiological processes during the development of transplant ...

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Mouse models are of special interest in research since a wide variety of monoclonal antibodies and commercially defined inbred and knockout strains are available to perform mechanistic in vivo studies. While heart transplantation models using a suture technique were first successfully developed in rats, the translation into an equally widespread used murine equivalent was never achieved due the technical complexity of the microsurgical procedure. In contrast, non-suture cuff techniques, also developed initially in rats, were successfully adapted for use in mice1-3. This technique for revascularization involves two major steps I) everting the recipient vessel over a polyethylene cuff; II) pulling the donor vessel over the formerly everted recipient vessel and holding it in place with a circumferential tie. This ensures a continuity of the endothelial layer, short operating time and very high patency rates4.
Using this technique for vascular anastomosis we performed more than 1,000 cervical heart transplants with an overall success rate of 95%. For arterial inflow the common carotid artery and the proximal aortic arch were anastomosed resulting in a retrograde perfusion of the transplanted heart. For venous drainage the pulmonary artery of the graft was anastomosed with the external jugular vein of the recipient5.
Herein, we provide additional details of this technique to supplement the video.

The murine cervical heart transplantation model is well suited for immunological as well as ischemia reperfusion injury studies. We modified the procedure using a non-suture cuff technique and performed more than 1,000 successful transplants with this approach.
Herein, we provide additional details of this technique to supplement the video.

Mouse models are of special interest in research since a wide variety of monoclonal antibodies and commercially defined inbred and knockout strains are ...

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Tissue engineered heart valves, especially decellularized valves, are starting to gain momentum in clinical use of reconstructive surgery with mixed results. However, the cellular and molecular mechanisms of the neotissue development, valve thickening, and stenosis development are not researched extensively. To answer the above questions, we developed a murine heterotopic heart valve transplantation model. A heart valve was harvested from a valve donor mouse and transplanted to a heart donor mouse. The heart with a new valve was transplanted heterotopically to a recipient mouse. The transplanted heart showed its own heartbeat, independent of the recipient&#8217;s heartbeat. The blood flow was quantified using a high frequency ultrasound system with a pulsed wave Doppler. The flow through the implanted pulmonary valve showed forward flow with minimal regurgitation and the peak flow was close to 100 mm/sec. This murine model of heart valve transplantation is highly versatile, so it can be modified and adapted to provide different hemodynamic environments and/or can be used with various transgenic mice to study neotissue development in a tissue engineered heart valve.

In order to understand the cellular and molecular mechanisms underlying neotissue formation and stenosis development in tissue engineered heart valves, a murine model of heterotopic heart valve transplantation was developed. A pulmonary heart valve was transplanted to recipient using the heterotopic heart transplantation technique.

Tissue engineered heart valves, especially decellularized valves, are starting to gain momentum in clinical use of reconstructive surgery with mixed ...

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Heterotopic heart transplantation in rats has been a commonly used model for diverse immunological studies for more than 50 years. Several modifications have been reported since the first description in 1964. After 30 years of performing heterotopic heart transplantation in rats, we have developed a simplified surgical approach, which can be easily taught and performed without further surgical training or background.
After dissection of the ascending aorta and the pulmonary artery and ligation of superior and inferior caval and pulmonary veins, the donor heart is harvested and subsequently perfused with ice-cold saline solution supplemented with heparin. After clamping and incising the recipient abdominal vessels, the donor ascending aorta and pulmonary artery are anastomosed to the recipient abdominal aorta and inferior vena cava, respectively, using continuous running sutures.
Depending on different donor-recipient combinations, this model allows analyses of either acute or chronic rejection of allografts. The immunological significance of this model is further enhanced by a novel approach of in-ear injection of vital cardiac muscle cells and subsequent analysis of draining cervical lymphatic tissue.

We describe a model of heterotopic abdominal heart transplantation in rats, implying modifications of current strategies, which lead to a simplified surgical approach. Additionally, we describe a novel rejection model by in-ear injection of vital cardiac muscle cells, allowing further transplant immunological analyses in rats.

Heterotopic heart transplantation in rats has been a commonly used model for diverse immunological studies for more than 50 years. Several modifications ...

Immunology and Infection

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

There is an urgent clinical need for heart valve replacements that can grow in children. Heart valve transplantation is proposed as a new type of transplant with the potential to deliver durable heart valves capable of somatic growth with no requirement for anticoagulation. However, the immunobiology of heart valve transplants remains unexplored, highlighting the need for animal models to study this new type of transplant. Previous rat models for heterotopic aortic valve transplantation into the abdominal aorta have been described, though they are technically challenging and costly. For addressing this challenge, a renal subcapsular transplant model was developed in rodents as a practical and more straightforward method for studying heart valve transplant immunobiology. In this model, a single aortic valve leaflet is harvested and inserted into the renal subcapsular space. The kidney is easily accessible, and the transplanted tissue is securely contained in a subcapsular space that is well vascularized and can accommodate a variety of tissue sizes. Furthermore, because a single rat can provide three donor aortic leaflets and a single kidney can provide multiple sites for transplanted tissue, fewer rats are required for a given study. Here, the transplantation technique is described, providing a significant step forward in studying the transplant immunology of heart valve transplantation.

This protocol describes a simple and efficient method for the transplantation of aortic valve leaflets under the renal capsule to allow for the study of alloreactivity of heart valves.

There is an urgent clinical need for heart valve replacements that can grow in children. Heart valve transplantation is proposed as a new type of ...

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Cardiac allograft rejection limits the long-term survival of patients after heart transplantation. A mouse heart transplantation model is ideal for investigating the mechanism of cardiac allograft rejection in preclinical studies because of their high homology with human genes. This understanding would help develop unique approaches to improving patients&#39; long-term survival treated with cardiac allografts. In a mouse model, abdominal donor heart implantation is commonly performed with an end-to-end&#160;anastomosis to the recipient&#39;s aorta and inferior vena cava using stitches. In this model, the donor&#39;s heart is implanted by end-to-end anastomosis to the recipient&#39;s carotid artery and jugular vein by the modified-Cuff technique. The transplantation surgery is performed without stitching and thus may increase the survival of the recipient since there is no interference with the blood supply and venous reflux of the lower body. This mouse model would help investigate the mechanisms underlying the immunological and pathological (acute/chronic) rejection of cardiac allografts.

In the present protocol, a mouse heart transplantation model is used for investigating the mechanism of cardiac allograft rejection. In this heterotopic heart transplantation model, operation efficiency is improved, and the survival of cardiac grafts is ensured by a cervical end-to-end anastomosis of heart implantation using a modified Cuff technique.

Cardiac allograft rejection limits the long-term survival of patients after heart transplantation. A mouse heart transplantation model is ideal for ...

A Heterotopic Rat Heart Transplantation Model using Circulatory Death Donor Hearts

The objective of this protocol is to set up a rat heterotopic heart transplantation model with donation after circulatory death (DCD) donor hearts. There are two setups for this protocol: heart donor setup and recipient setup. In the heart donor setup, Sprague Dawley rats are anesthetized, endotracheally intubated, and ventilated. The right carotid artery is cannulated to deliver heparin and the paralytic agent vecuronium-bromide. The DCD process is initiated by terminating the ventilation. After 20 min, the heart is exposed and the aorta distal to the brachiocephalic branch is clamped. At 25 min from terminating the ventilator, ice-cold University of Wisconsin (UW) solution is perfused through the carotid catheter to flush the heart. The heart is procured by dividing the aorta, pulmonary artery, venae cavae, and pulmonary veins and stored in UW solution for implantation. In the recipient setup, the Lewis rat is anesthetized with isoflurane. Slow-release buprenorphine is administered subcutaneously to facilitate a smooth postoperative recovery. Through a midline abdominal incision, the infra-renal aorta and the inferior vena cava are isolated and clamped with an atraumatic vascular clamp. The donor heart aorta and pulmonary artery are sutured to the recipient abdominal aorta and vena cava, respectively, with a running 8-0 Prolene. The vascular clamp is removed to reperfuse the heart. The abdominal wall is closed and the rat is recovered. After a set interval (24 h to 2 weeks), the recipient rat is anesthetized, the transplanted heart is exposed, and a balloon-tip-catheter is inserted into the left ventricle via the apex to record developed pressure and dP/dt using a data acquisition system. The heart tissue is collected for histology, immunology, or molecular analysis. A successful DCD donor rat heart transplantation model will allow further studies on the cardioprotective approaches to improve heart transplantation outcomes from DCD donors.

Here, we describe the preparation and technical details of murine heterotopic heart transplantation utilizing a circulatory death donor heart.

The objective of this protocol is to set up a rat heterotopic heart transplantation model with donation after circulatory death (DCD) donor hearts. There ...

Rat Model of Normothermic Ex-Situ Perfused Heterotopic Heart Transplantation

Heart transplantation is the most effective therapy for end-stage heart failure. Despite the improvements in therapeutic approaches and interventions, the number of heart failure patients waiting for transplantation is still increasing. The normothermic ex situ preservation technique has been established as a comparable method to the conventional static cold storage technique. The main advantage of this technique is that donor hearts can be preserved for up to 12 h in a physiologic condition. Moreover, this technique allows resuscitation of the donor hearts after circulatory death and applies required pharmacologic interventions to improve donor function after implantation. Numerous animal models have been established to improve normothermic ex situ preservation techniques and eliminate preservation-related complications. Although large animal models are easy to handle compared to small animal models, it is costly and challenging. We present a rat model of normothermic ex situ donor heart preservation followed by heterotopic abdominal transplantation. This model is relatively cheap and can be accomplished by a single experimenter.

Here, we present an assessment protocol of a heterotopically implanted heart after normothermic ex situ preservation in the rat model.

Heart transplantation is the most effective therapy for end-stage heart failure. Despite the improvements in therapeutic approaches and interventions, the ...

Modified Heterotopic Abdominal Heart Transplantation and a Novel Aortic Regurgitation Model in Rats

Over the past 50 years, many researchers have reported heterotopic abdominal heart transplantation in mice and rats, with some variations in the surgical technique. Modifying the transplantation procedure to strengthen the myocardial protection could prolong the ischemia time while preserving the donor&#39;s cardiac function. This technique&#39;s key points are as follows: transecting the donor&#39;s abdominal aorta before harvesting to unload the donor&#39;s heart; perfusing the donor&#39;s coronary arteries with a cold cardioplegic solution; and topical cooling of the donor&#39;s heart during the anastomosis procedure. Consequently, since this procedure prolongs the acceptable ischemia time, beginners can easily perform it and achieve a high success rate.
Moreover, a new aortic regurgitation (AR) model was established in this work using a technique different from the existing one,&#160;which is created by inserting a catheter from the right carotid artery and puncturing the native aortic valve under continuous echocardiographic guidance. A heterotopic abdominal heart transplantation was performed using the novel AR model. In the protocol, after the donor&#39;s heart is harvested, a stiff guidewire is inserted into the donor&#39;s brachiocephalic artery and advanced toward the aortic root. The aortic valve is punctured by pushing the guidewire further even after the resistance is felt, thus inducing AR. It is easier to damage the aortic valve using this method than with the procedure described in the conventional AR model. Additionally, this novel AR model does not contribute to the recipient&#39;s circulation; therefore, this method is expected to produce a more severe AR model than the conventional procedure.

This study demonstrates a reproducible heterotopic abdominal heart transplantation technique in rats that beginners can learn and perform. Additionally, a novel aortic regurgitation model in rats is generated by performing heterotopic abdominal heart transplantation and damaging the donor's aortic valve using a guidewire after harvesting.

Over the past 50 years, many researchers have reported heterotopic abdominal heart transplantation in mice and rats, with some variations in the surgical ...

Liver Transplantation in Rats and Analyzing Allograft Patency

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Small animal transplant models are indispensable for organ tolerance studies investigating feasible therapeutic interventions in preclinical studies. Rat liver transplantation (LTx) protocols typically use an orthotopic model where the recipients&#39; native liver is removed and replaced with a donor liver. This technically demanding surgical procedure requires advanced micro-surgical skills and is further complicated by lengthy anhepatic and lower body ischemia times. This prompted the development of a less complicated heterotopic method that can be performed faster with no anhepatic or lower body ischemia time, reducing post-surgery stress for the recipient animal.
This heterotopic LTx protocol includes two main steps: excising the liver from the donor rat and transplanting the whole liver into the recipient rat. During the excision of the donor liver, the surgeon ligates the supra-hepatic vena cava (SHVC) and hepatic artery (HA). On the recipient side, the surgeon removes the left kidney and positions the donor liver with the portal vein (PV), infra-hepatic vena cava (IHVC), and bile duct facing the renal vessels. Further, the surgeon anastomoses the recipient&#39;s renal vein end to end with the IHVC of the liver and arterializes the PV with the renal artery using a stent. A hepaticoureterostomy is utilized for biliary drainage by anastomosing the bile duct to the recipient&#39;s ureter, permitting the discharge of bile via the bladder.
The average duration of the transplantation was 130 min, cold ischemia duration was around 35 min, and warm ischemia duration was less than 25 min. Hematoxylin and eosin histology of the auxiliary liver from syngeneic transplants showed normal hepatocyte structure with no significant parenchymal alterations 30 days post-transplant. In contrast, 8-day post-transplant allogeneic graft specimens demonstrated extensive lymphocytic infiltration with a Banff Schema rejection activity index score of 9. Therefore, this LTx method facilitates a low morbidity rejection model alternative to orthotopic LTx.

The rat heterotopic auxiliary liver transplant protocol described here offers a practical investigational tool for exploring mechanisms of hepatic allograft rejection. This model helps to alleviate the surgical hurdles and animal stress of orthotopic liver transplantation in rats.

Small animal transplant models are indispensable for organ tolerance studies investigating feasible therapeutic interventions in preclinical studies. Rat ...